{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:49:31Z","timestamp":1790747371027,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clnu.2024.04.013","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T13:49:01Z","timestamp":1713188941000},"page":"1291-1298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A\u00a0multicenter study"],"prefix":"10.1016","volume":"43","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anning","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7133-6909","authenticated-orcid":false,"given":"Zhishun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2024.04.013_bib1","first-page":"14","article-title":"Improving food-related quality of life in inflammatory bowel disease through a novel web resource: a feasibility randomised controlled trial","author":"Cox","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2024.04.013_bib2","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2024.04.013_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1053\/j.gastro.2018.06.035","article-title":"Efficacy of ustekinumab for inducing endoscopic healing in patients with Crohn\u2019s disease","volume":"155","author":"Rutgeerts","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.04.013_bib4","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn\u2019s disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2024.04.013_bib5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.clinthera.2018.07.013","article-title":"Treatment patterns and sequencing in patients with inflammatory bowel disease","volume":"40","author":"Brady","year":"2018","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.clnu.2024.04.013_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/CEG.S109696","article-title":"Systematic review: treatment pattern and clinical effectiveness and safety of pharmaceutical therapies for Crohn\u2019s disease in Europe","volume":"9","author":"Lelli","year":"2016","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.clnu.2024.04.013_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/apt.13083","article-title":"Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed","volume":"41","author":"Gisbert","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2024.04.013_bib8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s10620-018-5385-9","article-title":"Real-world success of biologic therapy in IBD: No more reasons to Be anti antibody","volume":"64","author":"Gordon","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2024.04.013_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","article-title":"Influence of immunogenicity on the long-term efficacy of infliximab in Crohn\u2019s disease","volume":"348","author":"Baert","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2024.04.013_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/gastro\/gou087","article-title":"Optimizing the use of biological therapy in patients with inflammatory bowel disease","volume":"3","author":"Moss","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.clnu.2024.04.013_bib11","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.cgh.2019.04.040","article-title":"Should we divide Crohn\u2019s disease into ileum-dominant and isolated colonic diseases?","volume":"17","author":"Dulai","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.04.013_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gutjnl-2016-312673","article-title":"Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?","volume":"66","author":"Subramanian","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2024.04.013_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2024.04.013_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1007\/s10620-018-5041-4","article-title":"Colonic Crohn\u2019s disease is associated with less aggressive disease course than ileal or ileocolonic disease","volume":"63","author":"Arora","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2024.04.013_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","article-title":"Crohn\u2019s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial","volume":"157","author":"Levine","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.04.013_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrgastro.2009.203","article-title":"Clinical implications of mucosal healing for the management of IBD","volume":"7","author":"Pineton de Chambrun","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.04.013_bib17","first-page":"11","article-title":"Exclusive enteral nutrition: clinical effects and changes in mucosal cytokine profile in pediatric new inflammatory bowel disease","author":"Rolandsdotter","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2024.04.013_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/nu9050447","article-title":"The impact of exclusive enteral nutrition (EEN) on the gut microbiome in Crohn\u2019s disease: a review","volume":"9","author":"MacLellan","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2024.04.013_bib19","first-page":"CD000542","article-title":"Enteral nutritional therapy for induction of remission in Crohn\u2019s disease","volume":"4","author":"Narula","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2024.04.013_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","article-title":"ESPEN guideline: clinical nutrition in inflammatory bowel disease","volume":"36","author":"Forbes","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2024.04.013_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/apt.15425","article-title":"The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction","volume":"50","author":"Logan","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2024.04.013_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/MCG.0000000000000041","article-title":"Exclusive enteral nutritional therapy can relieve inflammatory bowel stricture in Crohn\u2019s disease","volume":"48","author":"Hu","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clnu.2024.04.013_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/gastro\/goy050","article-title":"Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn\u2019s disease","volume":"7","author":"Chen","year":"2019","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.clnu.2024.04.013_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clnu.2022.12.004","article-title":"ESPEN guideline on Clinical Nutrition in inflammatory bowel disease","volume":"42","author":"Bischoff","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2024.04.013_bib25","doi-asserted-by":"crossref","first-page":"9974","DOI":"10.3748\/wjg.v21.i34.9974","article-title":"Clinical utility of a new endoscopic scoring system for Crohn\u2019s disease","volume":"21","author":"Morise","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2024.04.013_bib26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cgh.2019.08.024","article-title":"Small bowel healing detected by endoscopy in patients with Crohn\u2019s disease after treatment with antibodies against tumor necrosis factor","volume":"18","author":"Takenaka","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.04.013_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.gastro.2019.06.038","article-title":"Endoscopic, radiologic, and histologic healing with vedolizumab in\u00a0patients\u00a0with active Crohn\u2019s disease","volume":"157","author":"Danese","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.04.013_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2036.2000.00707.x","article-title":"Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn\u2019s disease","volume":"14","author":"Fell","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2024.04.013_bib29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00535-013-0815-0","article-title":"Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease","volume":"49","author":"Grover","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.clnu.2024.04.013_bib30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","article-title":"Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease","volume":"8","author":"Ruemmele","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2024.04.013_bib31","first-page":"995","article-title":"Efficacy of exclusive enteral nutrition in complicated Crohn\u2019s disease","volume":"52","author":"Yang","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clnu.2024.04.013_bib32","doi-asserted-by":"crossref","first-page":"3813915","DOI":"10.1155\/2022\/3813915","article-title":"Outcomes of pediatric patients with Crohn\u2019s disease received infliximab or exclusive enteral nutrition during induction remission","volume":"2022","author":"Lv","year":"2022","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.clnu.2024.04.013_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: Part 1: diagnosis and medical management","volume":"11","author":"Gomollon","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2024.04.013_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MEG.0b013e32832c788c","article-title":"Enteral nutrition for the maintenance of remission in Crohn\u2019s disease: a systematic review","volume":"22","author":"Yamamoto","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.04.013_bib35","doi-asserted-by":"crossref","first-page":"5947926","DOI":"10.1155\/2016\/5947926","article-title":"Infliximab combined with enteral nutrition for managing Crohn\u2019s disease complicated with intestinal fistulas","volume":"2016","author":"Wu","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.clnu.2024.04.013_bib36","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s10620-012-2374-2","article-title":"Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn\u2019s disease in adults","volume":"58","author":"Hirai","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2024.04.013_bib37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.5217\/ir.2018.16.3.494","article-title":"Effect of elemental diet combined with infliximab dose escalation in patients with Crohn\u2019s disease with loss of response to infliximab: CERISIER trial","volume":"16","author":"Hisamatsu","year":"2018","journal-title":"Intest Res"},{"key":"10.1016\/j.clnu.2024.04.013_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00535-019-01634-1","article-title":"Efficacy of\u00a0enteral nutrition in patients with Crohn\u2019s disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis","volume":"55","author":"Hirai","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.clnu.2024.04.013_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ibd.22977","article-title":"Mucosal healing\u00a0in\u00a0Crohn\u2019s disease: a systematic review","volume":"19","author":"De Cruz","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2024.04.013_bib40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0016-5107(99)80017-0","article-title":"Endoscopic and histologic healing of Crohn\u2019s (ileo-) colitis with azathioprine","volume":"50","author":"D\u2019Haens","year":"1999","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clnu.2024.04.013_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ibd.20777","article-title":"Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn\u2019s disease","volume":"15","author":"Mantzaris","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2024.04.013_bib42","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1053\/j.gastro.2021.09.078","article-title":"Breaking through the therapeutic ceiling: what will it take?","volume":"162","author":"Raine","year":"2022","journal-title":"Gastroenterology"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T01:43:31Z","timestamp":1716860611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0261561424001195"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.04.013","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A\u00a0multicenter study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}